Related Experiment Video
Updated: Jun 11, 2026
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
HIV vaccine acceptability: a systematic review and meta-analysis
1University of Toronto, Factor-Inwentash Faculty of Social Work, Centre for Applied Social Research, Toronto, Ontario, Canada. p.newman@utoronto.ca
AIDS (London, England)
|July 3, 2010
Summary
Public acceptance of future HIV vaccines is moderate, averaging 65.6%. Higher efficacy and perceived lower personal risk increase acceptability, while cost and safety concerns are barriers. Strategies should address these factors to improve uptake.
Area of Science:
- Public Health
- Vaccinology
- Epidemiology
Background:
- HIV remains a significant global health challenge.
- Development of an effective HIV vaccine is a priority.
- Understanding vaccine acceptability is crucial for successful implementation.
Purpose of the Study:
- To systematically review and analyze literature on HIV vaccine acceptability.
- To identify factors influencing the willingness of individuals to accept future HIV vaccines.
Main Methods:
- Systematic review and meta-analysis of peer-reviewed studies.
- Comprehensive search of electronic databases for relevant quantitative and qualitative research.
- Meta-analysis of studies reporting correlates and predictors of HIV vaccine acceptability.
Main Results:
- Twenty studies (n=7576) reported a weighted mean HIV vaccine acceptability of 65.6%.
- Higher vaccine efficacy (73.8% vs. 40.4%) and non-'risk group' membership significantly predicted higher acceptability.
- Barriers included pragmatic obstacles, cost, safety concerns, and fear; perceived susceptibility and benefits also played a role.
Conclusions:
- Public health strategies should emphasize vaccine benefits and accurate risk perception.
- Addressing fears, costs, and access barriers is essential for increasing HIV vaccine uptake.
- Interventions can enhance the effectiveness of HIV vaccines in epidemic control.
Related Concept Videos
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:27Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:51Vaccinations
Overview